We’re walking in Pankind’s #PutYourFootDown in #Sydney on March 23rd and cannot wait! If you can, please consider supporting us! pankind.grassrootz.com/2025-pyfd-sydn…..

Our latest publication in Science Advances is officially out! Here, we target the NPY/NPY1R signalling axis to lessen metastatic burden of mutant p53-dependent #PancreaticCancer 🔬👩🏼‍🔬 Check it out here: science.org/doi/10.1126/sc… Garvan Institute of Medical Research Invasion and Metastasis Lab

Today Team Pajic Lab proudly walked in Pankind’s #PutYourFootDown #Sydney to raise awareness for #PancreaticCancer. We raised over $1300 for pancreatic cancer research, and enjoyed the morning hugely. Thank you Garvan Institute of Medical Research for the outfits!

Not long now! Join us this Friday and learn about the latest developments in early phase oncology drug dev across AU and the world! Registrations still open and free for academic/NFP attendees. events.zoom.us/ev/AjHf5uaEMrC…

Yesterday at Garvan Institute of Medical Research’s 2025 I.D.E.A. Workshop our (very new!) PhD student Bratati presented her proposed work in translating preclinical findings in repurposing anti-fungals as a #PancreaticCancer therapy to the clinic, and won 3rd place! Great work, Bratati!

Pancreatic cancer remains one of the most aggressive and difficult-to-treat cancers, with a 5-year survival rate of less than 13%. Hear from our leading experts on the latest clinical trials at our upcoming public seminar. Click here to attend: ow.ly/b9S950VK7sr

Find out how our research is breaking the barriers to treating pancreatic cancer at our upcoming public seminar. This seminar is being held on Wednesday 18 June, don't miss out! Click here to attend: ow.ly/X5Cq50VOaqC

Pancreatic cancer is usually found late, with over 80% of people diagnosed at stage four. We're working hard to find targeted treatment options that give patients a better chance of survival. Find out more: ow.ly/Pzn250VSbwy #cancer #pancreaticcancer #cancerpatients

Did you know pancreatic cancer is predicted to become the second most common cancer in Australia by 2030? With survival rates currently under 13%, we’re aiming to increase that to 30% by 2030. ow.ly/n4fU50VRxHE #garvan #pancreaticcancer #cancer #medicalresearch

At Garvan, researchers are investigating new personalised treatment strategies that are offering new hope to patients facing a pancreatic cancer diagnosis. Discover more at our upcoming public seminar. Click here: ow.ly/fxhr50VZM2C

Save the date! OzMRS Symposium 2025 will take place at UOW on the 29th and 30th of October. More information coming soon. #Metastasis #CancerResearch

Hear from our lab head Marina Pajic about the work our lab is doing in #CancerResearch to improve outcomes for patients with #PancreaticCancer.

Our lab head Marina Pajic, along with GrumpyOncologist and Purple Our World’s Daniel Goulburn OAM delivered an inspiring public seminar today at Garvan Institute of Medical Research on how we are working to improve outcomes for patients with #PancreaticCancer.

Couldn't attend our recent seminar? Hear from our world-leading pancreatic cancer researchers as they share insights on the latest clinical trials and personalised treatment strategies, bringing new hope to families facing a diagnosis. Watch here: youtu.be/40hMRNgJGkg?si…

Catch the best moments from the 2025 Snow Fellows Conference in this short highlight video! Celebrate the achievements of this year’s Snow Fellows and get a glimpse into their inspiring work and impact. youtu.be/fhnzSHPVFDA

We’re excited to introduce our next monthly featured "Get to Know the Cancer Researcher" video, Professor Marina Pajic from Garvan Institute of Medical Research Watch here: boxrallies.com/our-researchers

🎥 BOX RALLIES RESEARCH FILMS - Professor Marina Pajic - Pancreatic Cancer Researcher at Garvan Institute of Medical Research Marina and her team have identified a molecular pathway that controls communication between pancreatic cancer cells and stromal cells. Head to boxrallies.com

Our latest publication in Molecular Cancer Therapeutics is out! We've developed a new patient-derived model of a rare cancer, TFCP2-rearranged intraosseous rhabdomyosarcoma, and validated a promising preclinical treatment approach for this disease. doi.org/10.1158/1535-7… Garvan Institute of Medical Research Personalised Cancer Therapeutics Lab

Personalised Cancer Therapeutics Lab is thrilled to be at Day 2 of the #NSWCancerSummit2025! Yesterday’s talks were incredibly inspiring and we can’t wait to hear more. Postdocs Dannel Yeo Diana Schuhmacher Deanna Miller and PhD student Johana have posters - come and see us if you’re here! Cancer Institute NSW

Registration and abstract submissions are now open for the 7th OzMRS Scientific Symposium, being held on the 29-30th October at UOW. Talks, flash talks, and poster presentations are available, so please submit abstracts before September 27th! #metastasis